Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
NCT02425748
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
BIOLOGICAL:
DC-CIK
BIOLOGICAL:
γδ T Cell
BIOLOGICAL:
γδ T/DC-CIK cells
Sponsor
Fuda Cancer Hospital, Guangzhou
Collaborators
[object Object]